Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-01 6:22 pm Purchase |
2024-01-22 | 13G | Dianthus Therapeutics, Inc. DNTH |
RA Capital Management, L.P. | 2,995,023 9.990% |
2,995,023![]() (New Position) |
Filing History |
2024-01-31 12:11 pm Purchase |
2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 2,922,823 9.900% |
2,922,823![]() (New Position) |
Filing History |
2024-01-24 5:26 pm Purchase |
2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 2,960,747 9.900% |
1,086,914![]() (+58.00%) |
Filing History |
2023-11-13 09:02 am Purchase |
2023-11-10 | 13G | Dianthus Therapeutics, Inc. DNTH |
FMR CORP | 2,218,212 14.970% |
2,218,212![]() (New Position) |
Filing History |
2023-09-21 4:34 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Viridian LLC | 1,090,283 7.400% |
1,090,283![]() (New Position) |
Filing History |
2023-09-21 4:32 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 1,873,833 12.700% |
1,873,833![]() (New Position) |
Filing History |
2023-09-21 4:15 pm Purchase |
2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH |
5AM Partners VII, LLC | 1,482,320 10.000% |
1,482,320![]() (New Position) |
Filing History |
2023-09-21 4:15 pm Purchase |
2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH |
Venrock Healthcare Capital Partners III L.P. | 927,706 6.300% |
927,706![]() (New Position) |
Filing History |
2023-09-15 4:56 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Atlas Venture Fund X L.P. | 186,089 1.300% |
186,089![]() (New Position) |
Filing History |
2023-05-15 4:47 pm Purchase |
2023-05-03 | 13G | Magenta Therapeutics, Inc. MGTA |
Citadel Advisors LLC | 4,087,110 6.700% |
4,087,110![]() (New Position) |
Filing History |
2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 0 0.000% |
-3,588,081![]() (Position Closed) |
Filing History |
2023-02-14 11:12 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Aquilo Capital Management LLC | 0 0.000% |
-3,155,082![]() (Position Closed) |
Filing History |
2023-02-14 08:47 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 3,000,000 4.950% |
-1,870,000![]() (-38.40%) |
Filing History |
2023-02-14 06:09 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 425,858 0.700% |
-3,249,750![]() (-88.41%) |
Filing History |
2023-02-13 9:31 pm Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 0 0.000% |
-3,901,589![]() (Position Closed) |
Filing History |
2023-02-13 4:00 pm Purchase |
2023-02-03 | 13G | Magenta Therapeutics, Inc. MGTA |
TANG CAPITAL PARTNERS LP | 5,880,933 9.700% |
5,880,933![]() (New Position) |
Filing History |
2022-09-27 10:40 am Unchanged |
2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 3,588,081 6.090% |
0 (Unchanged) |
Filing History |
2022-09-26 4:37 pm Purchase |
2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 3,588,081 6.090% |
3,588,081![]() (New Position) |
Filing History |
2022-05-05 4:01 pm Sale |
2021-04-13 | 13D | Magenta Therapeutics, Inc. MGTA |
Atlas Venture Fund X L.P. | 2,977,448 5.100% |
-379,892![]() (-11.32%) |
Filing History |
2022-02-14 4:53 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Third Rock Ventures IV L.P. | 6,758,204 11.500% |
6,758,204![]() (New Position) |
Filing History |